Back to search

Article

Targeting High Glucose-Induced Epigenetic Modifications at Cardiac Levels: The Role of SGLT2 and SGLT2 Inhibitors

2022-11-29

Abstract excerpt

<h4>Background: </h4> Sodium-glucose co-transporters inhibitors showed many beneficial effects at the cardiovascular level. Several mechanisms of action have been identified. However, no data are reported on their capability to act via epigenetic mechanisms. Therefore, this study aimed to investigate the ability of SGLT2 inhibitors to induce protective effects at the cardiovascular level by acting on DNA methylati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1d67c74-3d6b-547c-bf4e-300799cc1057
DOI
10.21203/rs.3.rs-2300456/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting High Glucose-Induced Epigenetic Modifications at Cardiac Levels: The Role of SGLT2 and SGLT2 InhibitorsDOI 10.21203/rs.3.rs-2300456/v1
Select a neighboring publication to make it the new centre.